Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only ...

Jamie Baumgartner, Jonathan Grinstein, and John Wilkerson go behind the headlines to discuss the implications of personalized gene-editing therapies, more HHS policy and funding updates, and the ...

ACG partnered with Art of You to launch the world-first Personalised Capsule Machine, enabling on-demand, customized ...

The LP.8.1 variant of the SARS-CoV-2 virus differs from the JN.1 family that previous vaccines had been designed to target, ...

Researchers say they have discovered the first drug mechanism that binds to the pyrin domain to block NLRP3 and prevent a series of reactions resulting in inflammation.

At the 2025 edition of the International Society of Pharmaceutical Engineering (ISPE) Europe Annual Conference, held in ...

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields. Merck KGaA (Merck), headquartered in Darmstadt, Germany, and Israel ...